ALT stock forecast
Our latest prediction for Altimmune, Inc.'s stock price was made on the Sept. 5, 2019 when the stock price was at 2.06$.
In the short term (2weeks), ALT's stock price should outperform the market by 5.76%. During that period the price should oscillate between -7.10% and +13.37%.
In the medium term (3months), ALT's stock price should outperform the market by 9.46%. During that period the price should oscillate between -17.76% and +40.92%.Get email alerts
About Altimmune, Inc.
Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
At the moment the company generates 10M USD in revenues.
On its last earning announcement, the company reported a profit of 2.56$ per share.
The book value per share is 24.98$
Three months stock forecastSept. 5, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|